X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (80) 80
humans (61) 61
gastroenterology & hepatology (43) 43
male (37) 37
female (36) 36
middle aged (30) 30
adult (29) 29
gastroenterology and hepatology (25) 25
610 medicine & health (24) 24
inflammatory bowel disease (23) 23
aged (22) 22
clinic for gastroenterology and hepatology (20) 20
crohns-disease (20) 20
risk factors (20) 20
ulcerative-colitis (20) 20
prevalence (17) 17
young adult (16) 16
diagnosis (15) 15
adolescent (14) 14
ulcerative colitis (13) 13
animals (12) 12
crohn's disease (12) 12
risk-factors (12) 12
aged, 80 and over (11) 11
care and treatment (11) 11
inflammatory-bowel-disease (11) 11
patients (11) 11
gastroenterology (10) 10
health aspects (10) 10
intestine (10) 10
medicine, general & internal (10) 10
research (10) 10
treatment outcome (10) 10
analysis (9) 9
biochemistry & molecular biology (9) 9
child (9) 9
disease (9) 9
inflammation (9) 9
inflammatory bowel diseases (9) 9
prospective studies (9) 9
proteins (9) 9
surgery (9) 9
switzerland - epidemiology (9) 9
colon (8) 8
extraintestinal manifestations (8) 8
mice (8) 8
multidisciplinary sciences (8) 8
abridged index medicus (7) 7
immunology (7) 7
infection (7) 7
management (7) 7
medical research (7) 7
medicine, experimental (7) 7
retrospective studies (7) 7
symptoms (7) 7
usage (7) 7
activation (6) 6
anticoagulants (6) 6
cancer (6) 6
child, preschool (6) 6
colitis (6) 6
crohn’s disease (6) 6
digestive system diseases (6) 6
follow-up studies (6) 6
hela cells (6) 6
irritable-bowel-syndrome (6) 6
liver (6) 6
logistic models (6) 6
multivariate analysis (6) 6
prevention (6) 6
research article (6) 6
risk (6) 6
salmonella (6) 6
salmonella typhimurium - pathogenicity (6) 6
abdomen (5) 5
bacteria (5) 5
binding sites (5) 5
biology and life sciences (5) 5
cell biology (5) 5
cells (5) 5
crohn disease - diagnosis (5) 5
diarrhea (5) 5
endoscopy (5) 5
epithelial-cells (5) 5
genetic aspects (5) 5
hepatology (5) 5
hospitals (5) 5
ibd (5) 5
iii secretion (5) 5
infections (5) 5
internal medicine (5) 5
medicine (5) 5
medicine & public health (5) 5
medicine and health sciences (5) 5
mice, inbred c57bl (5) 5
microbiology (5) 5
motility (5) 5
oncology (5) 5
pathogens (5) 5
population (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
Digestion, ISSN 0012-2823, 09/2014, Volume 90, Issue 1, pp. 72 - 73
Journal Article
by Yilmaz, Bahtiyar and Juillerat, Pascal and Øyås, Ove and Ramon, Charlotte and Bravo, Francisco Damian and Franc, Yannick and Fournier, Nicolas and Michetti, Pierre and Mueller, Christoph and Geuking, Markus and Pittet, Valerie E. H and Maillard, Michel H and Rogler, Gerhard and Abdelrahman, Karim and Ademi, Gentiana and Aepli, Patrick and Thomas, Amman and Anderegg, Claudia and Antonino, Anca-Teodora and Archanioti, Eva and Arrigoni, Eviano and Bakker de Jong, Diana and Balsiger, Bruno and Bastürk, Polat and Bauerfeind, Peter and Becocci, Andrea and Belli, Dominique and Bengoa, José M and Biedermann, Luc and Binek, Janek and Blattmann, Mirjam and Boehm, Stephan and Boldanova, Tujana and Borovicka, Jan and Braegger, Christian P and Brand, Stephan and Brügger, Lukas and Brunner, Simon and Bühr, Patrick and Burnand, Bernard and Burk, Sabine and Burri, Emanuel and Buyse, Sophie and Cao, Dahlia-Thao and Carstens, Ove and Criblez, Dominique H and Cunningham, Sophie and D’Angelo, Fabrizia and de Saussure, Philippe and Degen, Lukas and Delarive, Joakim and Doerig, Christopher and Dora, Barbara and Drerup, Susan and Egger, Mara and El-Wafa, Ali and Engelmann, Matthias and Ezri, Jessica and Felley, Christian and Fliegner, Markus and Fournier, Nicolas and Fraga, Montserrat and Franc, Yannick and Frei, Pascal and Frei, Remus and Fried, Michael and Froehlich, Florian and Furlano, Raoul Ivano and Garzoni, Luca and Geyer, Martin and Girard, Laurent and Girardin, Marc and Golay, Delphine and Good, Ignaz and Graf Bigler, Ulrike and Gysi, Beat and Haarer, Johannes and Halama, Marcel and Haldemann, Janine and Heer, Pius and Heimgartner, Benjamin and Helbling, Beat and Hengstler, Peter and Herzog, Denise and Hess, Cyrill and Hessler, Roxane and Heyland, Klaas and Hinterleitner, Thomas and Hirschi, Claudia and Hruz, Petr and Juillerat, Pascal and Khalid-de Bakker, Carolina and Kayser, Stephan and Keller, Céline and Knellwolf (-Grieger), Christina and Knoblauch, Christoph and Köhler, Henrik and Koller, Rebekka and Krieger(-Grübel), Claudia and Künzler, Patrizia and ... and Swiss IBD Cohort Investigators
Nature Medicine, ISSN 1078-8956, 02/2019, Volume 25, Issue 2, pp. 323 - 336
Inflammatory bowel diseases (IBD) can be broadly divided into Crohn’s disease (CD) and ulcerative colitis (UC) from their clinical phenotypes. Over 150 host... 
Phenotypes | Inflammatory bowel diseases | Disease | Medical treatment | Health risks | Antibodies | Tumor necrosis factor-α | Fatty acids | Patients | Refractory materials | Microorganisms | Replicating | Intestine | Disturbances | Remission | Ulcerative colitis
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
Case Reports in Gastroenterology, ISSN 1662-0631, 11/2017, Volume 11, Issue 3, pp. 724 - 728
Infection with Yersinia enterocolitica (YE) typically presents with mild gastroenteritis without systemic infection. However, systemic YE infection has been... 
Single Case | Iron overload | Yersinia enterocolitica | Sepsis | Hemochromatosis | Hepatic abscess | Pathogens | Internal medicine | Laboratories | Liver | Infections | Patients | Abdomen | Medicine | Hospitals | Antibiotics | Gastroenterology | Insulin resistance | Bacteria | Diabetes
Journal Article
BMJ Case Reports, ISSN 1757-790X, 05/2019, Volume 12, Issue 5, p. e228356
Acute hepatitis remains a diagnostic challenge, and numerous infectious, metabolic and autoimmune diseases need to be effectively excluded. We present a case... 
Antigens | Cytomegalovirus | Immunoglobulins | Disease | Anemia | Liver | Smooth muscle | Infections | Phosphatase | Patients | Fever | Abdomen | Hepatitis | Ultrasonic imaging | Mononucleosis | Human immunodeficiency virus--HIV
Journal Article
Molecular Systems Biology, ISSN 1744-4292, 03/2011, Volume 7, Issue 1, pp. 474 - n/a
The pathogen Salmonella Typhimurium is a common cause of diarrhea and invades the gut tissue by injecting a cocktail of virulence factors into epithelial... 
HeLa | systems biology | Salmonella | siRNA | coatomer | LISTERIA-MONOCYTOGENES | CONTAINING VACUOLES | ENTERICA SEROVAR TYPHIMURIUM | BIOCHEMISTRY & MOLECULAR BIOLOGY | ESCHERICHIA-COLI | III SECRETION | MEDIATED ENDOCYTOSIS | INFLUENZA-VIRUS REPLICATION | ACTIN CYTOSKELETON | VESICULAR STOMATITIS-VIRUS | HOST-PATHOGEN INTERACTIONS | Guanine Nucleotide Exchange Factors - genetics | Salmonella typhimurium - genetics | Salmonella typhimurium - pathogenicity | Humans | Salmonella Infections - genetics | Bacterial Proteins - genetics | cdc42 GTP-Binding Protein - metabolism | Salmonella Infections - metabolism | Cholesterol - metabolism | Coat Protein Complex I - genetics | Coat Protein Complex I - metabolism | Salmonella typhimurium - metabolism | RNA, Small Interfering - chemistry | Endocytosis | Phenotype | RNA Interference | Guanine Nucleotide Exchange Factors - metabolism | cdc42 GTP-Binding Protein - genetics | Bacterial Proteins - metabolism | Salmonella Infections - microbiology | Virulence Factors - metabolism | Cell Membrane - metabolism | HeLa Cells | rac1 GTP-Binding Protein - metabolism | Cell culture | Regulators | Pathogenesis | Mucosa | Rafts | Tissue culture | Membrane ruffling | Assaying | Proteins | Hepatitis | Cell activation | Dependence | Public health | Binding | Pathogens | Diarrhea | Injection | Epithelium | Golgi apparatus | Screening | Stomatitis | Tuberculosis | Cytoskeleton | Toxins | Fluorescence microscopy | Cdc42 protein | Epithelial cells | Genes | Fluorescence | Lipids | Viruses | Lipid rafts | Genomes | Biology | Infections | Sphingolipids | Activation | Chlamydia trachomatis | Cell surface | Sexually transmitted diseases | Actin | Bacteria | Composition | Phenotypes | Secretion | Polymerization | Cholesterol | Depletion | Influenza | Hepatitis C virus | Hepatitis C | Index Medicus | Drugs | RNA-mediated interference | Rac1 protein | virulence factors | Plasma membranes | Digestive tract | Vacuoles | Guanosinetriphosphatase
Journal Article